Pediatric Urology, Ureteropelvic Junction Obstruction
Conditions
Keywords
patient centered outcomes
Brief summary
The objective is conduct a pilot randomized controlled trial comparing robotic and open techniques for surgical correction of congenital UPJ obstruction (pyeloplasty) in pediatric patients. This study will serve as a proof of concept trial to demonstrate feasibility of recruiting pediatric patients to participate in a randomized study for surgical procedures and delineate patient-centered outcomes. Should this study prove randomization is feasible, a randomized comparative effectiveness trial with sufficient power to determine whether open or robotic-assisted pyeloplasty has superior patient-centered outcomes will be pursued.
Detailed description
Technological innovations are an ongoing reality in clinical medicine, most dramatically in the operating room. Each advance is often heralded as an improvement in patient care, promising to correct deficiencies and advance standard operative procedures. Unfortunately, these new technologies often lack sufficient evidence to support such claims. Robotic assisted laparoscopic (RAL) surgery continues to gain popularity among pediatric surgical specialists, particularly for reconstructive procedures such as correction of ureteropelvic junction (UPJ) obstruction or vesicoureteral reflux (VUR).In these operations, where traditional open surgery yields a nearly 95% clinical success rate it is difficult to demonstrate improvement with a new surgical technique. Despite these impressive outcomes with the open approach many pediatric urologists are shifting towards newer RAL approaches, claiming faster recovery and improved cosmesis with a nominal increase in surgical cost. There is a striking dearth of comparative effectiveness research in pediatric surgical specialties, especially given the wide range of available therapies for a variety of surgical problems. Conducting randomized controlled trials of surgical interventions can be very difficult, especially in the pediatric population. Currently, all studies of pediatric robotic surgery have focused on traditional outcomes, e.g., length of stay, pain scores, pain medication usage, scar perception, cost analysis, and capital gains benefits. While these measures are important to study, the investigators believe that researchers must also focus on patients' treatment experiences or patients' evaluations of their own outcomes. By focusing on these 'patient-centered outcomes' the investigators will be able to improve outcomes from surgical procedures in ways that are most important to patients and their families. We propose a pilot randomized controlled trial comparing robotic and open techniques for surgical correction of congenital UPJ obstruction (pyeloplasty) in pediatric patients. This study will serve as a proof of concept trial to demonstrate feasibility of recruiting pediatric patients to participate in a randomized study for surgical procedures and delineate patient-centered outcomes. Should this study prove randomization is feasible, the investigators will seek funding to conduct a large, randomized comparative effectiveness trial with sufficient power to determine whether open or robotic-assisted pyeloplasty has superior patient-centered outcomes. The investigators propose to accomplish these goals with the following Specific Aims: Aim 1: Utilize novel patient-centered research methods to: * Identify outcomes of importance to patients and families related to pediatric pyeloplasty. * Determine patient and family preferences regarding acceptability of randomization and blinding of pediatric surgical patients and construct a recruitment approach to achieve enrollment. Aim 2: Conduct a randomized pilot study with goal of enrolling ten to twenty pediatric patients (age 2 - 8 years) to either open or robotic pyeloplasty for treatment of primary UPJ obstruction. Sub Aim 2a: Collect preliminary data regarding the patient-centered outcomes identified in Aim 1. Sub Aim 2b: Evaluate the effectiveness of the recruitment approach for randomized surgical studies developed in Aim 1. The investigators believe that the use of innovative and novel patient-centered research methods will lead to a significant breakthrough in developing a recruitment approach that is both acceptable to pediatric patients/families and optimizes participant willingness to participate in RCTs of surgical interventions. Additionally these same innovative research methods will allows the investigators to explore what outcomes are meaningful to patients and families, which will hopefully allow the care team to counsel patients and families in a way that maximizes their chances of achieving patient- and family-centered goals.
Interventions
Open approach for the surgical correction of UPJ obstruction
Robotic approach with the da Vinci Surgical System for the surgical correction of UPJ obstruction
Sponsors
Study design
Masking description
Patient, Family, and Nursing Staff on Surgical Floor
Intervention model description
For Aim 2: For the RCT, patients are randomized to either RALP or OP by using a pool of 20 cards of which 10 say robotic surgery and 10 say open surgery.
Eligibility
Inclusion criteria
For Aim 2: Inclusion Criteria: * Primary UPJ obstruction diagnosed by scan and presenting to the pediatric urology clinic for evaluation * Patient between age 2 - 8 years old
Exclusion criteria
* Serious comorbidities (cardiovascular or respiratory disease, or other congenital anomalies requiring surgical intervention). * BMI greater than the 95th %tile for age.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain Score Measured Using The FLACC at 2 Week Post Op Follow Up | 1 week post op follow up | Obtained from hospital record and participant report post discharge via the FLACC (behavioral scale for scoring postoperative pain in young children). FLACC score range: minimum 0 ( comfortable) and 10 (severe discomfort) |
| Length of Post Op Inpatient Hospital Stay Measured in Days | surgery to discharge | Number of inpatient hospital days post surgery obtained via retrospective chart. |
| Number of Doses of Narcotic Pain Medication In the First 24 Hours Post Op | Surgery to the first 24 hours post op | Pain medication use during hospitalization obtained via retrospective chart review. Dose recorded in mg and frequency recorded as number of doses administered in 24 hour period |
| Total Dose of Narcotic Pain Medication In the First 24 Hours Post Op in Morphine Milligram Equivalents (MME) | Surgery to the first 24 hours post op | Pain medication use during hospitalization obtained via retrospective chart review. Morphine milligram equivalents (MME) are values that represent the potency of an opioid dose relative to morphine |
| Grade of Surgical Complications up to 1 Year Post op Using Clavian-Dindo Classification | up to 1 year post up | This s a standardized scale to rank the severity of a surgical complication. The higher the grade the more severe the surgical complication. Minimum value is Grade 0 no complication to maximum Grade IV life threatening complication. Grades I thru IV defined as: Grade I Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions. This grade also includes wound infections opened at the bedside ; Grade II Requiring pharmacological treatment with drugs other than such allowed for grade I complications. Blood transfusionsand total parenteral nutritionare also included; Grade III Requiring surgical, endoscopic or radiological intervention; Grade IV Life-threatening complication (including CNS complications)\* requiring IC/ICU-management |
| Length Of Time For Patient To Return To Normal Routine After Surgery Measured in Days at 2 Week Post Follow Up | 2 week post op follow up | Study team created a questionnaire to better understand patient's post op experience. Participant to complete questionnaire with targeted questions on: Side effects of medication and impact; Experience of having a temporary ureteral stent; Ease of removing stent; Return to activity; Financial burden reported by family. No scale or scoring utilized to assess outcome. |
| Length Of Time Parent Was Out Of Work After Child's Surgery Measured in Days at 2 Week Post Follow Up | 2 week post op follow up | Number of days parent out of work after operation obtained by parent report. No scale or scoring utilized to assess outcome. Participant asked Have you returned to work since your child's surgery?. If Yes, asked to estimate the length of time you were out of work after your child's operation. |
| Satisfaction With Scar Appearance Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visit | up to 3 month follow up visit (18 weeks post op) | Participant completed the Patient Scar Assessment Questionnaire (PSAQ) at 3 month follow up visit. The 3 month follow up was scheduled at the 6 week post op visit. The Satisfaction with Appearance subscale consists of a 8 items with 4-point categorical responses, scoring 1 to 4 points (with 1 point assigned to the most favourable category and 4 assigned to the least favourable). The minimum score of this scale is an 8 and maximum 32. |
| Satisfaction With Symptoms Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visit | up to 3 month follow up visit (18 weeks post op) | The Patient Scar Assessment Questionnaire (PSAQ) was completed at the 3 month follow up (scheduled at the 6 week post op visit). Higher scores reflect a poorer perception of the scar related to the domain being evaluated. The Satisfaction with Symptoms subscale consists of a 5 items with 4-point categorical responses, scoring 1 to 4 points (with 1 point assigned to the most favourable category and 4 assigned to the least favourable). The minimum score of this scale is an 5 and maximum 20. |
| Quality of Life Measured Using The Glasgow Children's Benefit Inventory at 3 Month Follow Up Visit | 3 month follow up visit | Participant completed the GCBI at 3 month follow up visit. The 3 month follow up was scheduled at the 6 week post op visit. The Glasgow Children's Benefit Inventory (GCBI). is a 24 question 5 point Likert scale 2 (much better) to -2 (much worse) with scoring range from -100 (maximum harm) to +100 (maximum benefit). |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Robotic Surgery Robotic-Assisted Laparoscopic Pyeloplasty (RALP), standard of care treatment option for UPJ obstruction
Robotic-Assisted Laparoscopic Pyeloplasty (RALP): Robotic approach with the da Vinci Surgical System for the surgical correction of UPJ obstruction | 5 |
| Open Surgery Open Pyeloplasty (OP), standard of care treatment option for UPJ obstruction
Open Pyeloplasty (OP): Open approach for the surgical correction of UPJ obstruction | 6 |
| Total | 11 |
Baseline characteristics
| Characteristic | Robotic Surgery | Open Surgery | Total |
|---|---|---|---|
| Age, Customized Age 2 to 8 years | 5 Participants | 6 Participants | 11 Participants |
| Ethnicity (NIH/OMB) Hispanic or Latino | 0 Participants | 0 Participants | 0 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 5 Participants | 3 Participants | 8 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 3 Participants | 3 Participants |
| Region of Enrollment United States | 5 participants | 6 participants | 11 participants |
| Sex: Female, Male Female | 3 Participants | 0 Participants | 3 Participants |
| Sex: Female, Male Male | 2 Participants | 6 Participants | 8 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 5 | 0 / 6 |
| other Total, other adverse events | 0 / 5 | 0 / 6 |
| serious Total, serious adverse events | 0 / 5 | 0 / 6 |
Outcome results
Grade of Surgical Complications up to 1 Year Post op Using Clavian-Dindo Classification
This s a standardized scale to rank the severity of a surgical complication. The higher the grade the more severe the surgical complication. Minimum value is Grade 0 no complication to maximum Grade IV life threatening complication. Grades I thru IV defined as: Grade I Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions. This grade also includes wound infections opened at the bedside ; Grade II Requiring pharmacological treatment with drugs other than such allowed for grade I complications. Blood transfusionsand total parenteral nutritionare also included; Grade III Requiring surgical, endoscopic or radiological intervention; Grade IV Life-threatening complication (including CNS complications)\* requiring IC/ICU-management
Time frame: up to 1 year post up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Robotic Surgery | Grade of Surgical Complications up to 1 Year Post op Using Clavian-Dindo Classification | 0.6 grade on a scale | Standard Deviation 1.34 |
| Open Surgery | Grade of Surgical Complications up to 1 Year Post op Using Clavian-Dindo Classification | 0 grade on a scale | Standard Deviation 0 |
Length of Post Op Inpatient Hospital Stay Measured in Days
Number of inpatient hospital days post surgery obtained via retrospective chart.
Time frame: surgery to discharge
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Robotic Surgery | Length of Post Op Inpatient Hospital Stay Measured in Days | 1 days | Standard Deviation 0 |
| Open Surgery | Length of Post Op Inpatient Hospital Stay Measured in Days | 1 days | Standard Deviation 0 |
Length Of Time For Patient To Return To Normal Routine After Surgery Measured in Days at 2 Week Post Follow Up
Study team created a questionnaire to better understand patient's post op experience. Participant to complete questionnaire with targeted questions on: Side effects of medication and impact; Experience of having a temporary ureteral stent; Ease of removing stent; Return to activity; Financial burden reported by family. No scale or scoring utilized to assess outcome.
Time frame: 2 week post op follow up
Population: Participant asked At this point in your child's post op recovery, has your home routine returned to normal? If participant responded Yes then participant asked Estimate the length of time length of time it took to return to normal.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Robotic Surgery | Length Of Time For Patient To Return To Normal Routine After Surgery Measured in Days at 2 Week Post Follow Up | 7.67 days | Standard Deviation 5.03 |
| Open Surgery | Length Of Time For Patient To Return To Normal Routine After Surgery Measured in Days at 2 Week Post Follow Up | 6.5 days | Standard Deviation 3.73 |
Length Of Time Parent Was Out Of Work After Child's Surgery Measured in Days at 2 Week Post Follow Up
Number of days parent out of work after operation obtained by parent report. No scale or scoring utilized to assess outcome. Participant asked Have you returned to work since your child's surgery?. If Yes, asked to estimate the length of time you were out of work after your child's operation.
Time frame: 2 week post op follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Robotic Surgery | Length Of Time Parent Was Out Of Work After Child's Surgery Measured in Days at 2 Week Post Follow Up | 3.33 days | Standard Deviation 3.51 |
| Open Surgery | Length Of Time Parent Was Out Of Work After Child's Surgery Measured in Days at 2 Week Post Follow Up | 5 days | Standard Deviation 3.92 |
Number of Doses of Narcotic Pain Medication In the First 24 Hours Post Op
Pain medication use during hospitalization obtained via retrospective chart review. Dose recorded in mg and frequency recorded as number of doses administered in 24 hour period
Time frame: Surgery to the first 24 hours post op
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Robotic Surgery | Number of Doses of Narcotic Pain Medication In the First 24 Hours Post Op | 0.600 Number of Doses | Standard Deviation 0.55 |
| Open Surgery | Number of Doses of Narcotic Pain Medication In the First 24 Hours Post Op | 0.500 Number of Doses | Standard Deviation 0.55 |
Pain Score Measured Using The FLACC at 2 Week Post Op Follow Up
Obtained from hospital record and participant report post discharge via the FLACC (behavioral scale for scoring postoperative pain in young children). FLACC score range: minimum 0 ( comfortable) and 10 (severe discomfort)
Time frame: 1 week post op follow up
Population: FLACC scores 2 week post op
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Robotic Surgery | Pain Score Measured Using The FLACC at 2 Week Post Op Follow Up | 2.5 score on a scale | Standard Deviation 3.7 |
| Open Surgery | Pain Score Measured Using The FLACC at 2 Week Post Op Follow Up | 0 score on a scale | Standard Deviation 0 |
Quality of Life Measured Using The Glasgow Children's Benefit Inventory at 3 Month Follow Up Visit
Participant completed the GCBI at 3 month follow up visit. The 3 month follow up was scheduled at the 6 week post op visit. The Glasgow Children's Benefit Inventory (GCBI). is a 24 question 5 point Likert scale 2 (much better) to -2 (much worse) with scoring range from -100 (maximum harm) to +100 (maximum benefit).
Time frame: 3 month follow up visit
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Robotic Surgery | Quality of Life Measured Using The Glasgow Children's Benefit Inventory at 3 Month Follow Up Visit | 14.08 score on a scale | Standard Deviation 32.42 |
| Open Surgery | Quality of Life Measured Using The Glasgow Children's Benefit Inventory at 3 Month Follow Up Visit | 20.88 score on a scale | Standard Deviation 31.86 |
Satisfaction With Scar Appearance Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visit
Participant completed the Patient Scar Assessment Questionnaire (PSAQ) at 3 month follow up visit. The 3 month follow up was scheduled at the 6 week post op visit. The Satisfaction with Appearance subscale consists of a 8 items with 4-point categorical responses, scoring 1 to 4 points (with 1 point assigned to the most favourable category and 4 assigned to the least favourable). The minimum score of this scale is an 8 and maximum 32.
Time frame: up to 3 month follow up visit (18 weeks post op)
Population: Satisfaction with Appearance at 3 month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Robotic Surgery | Satisfaction With Scar Appearance Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visit | 10.25 score on a scale | Standard Deviation 3.86 |
| Open Surgery | Satisfaction With Scar Appearance Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visit | 11.40 score on a scale | Standard Deviation 3.05 |
Satisfaction With Symptoms Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visit
The Patient Scar Assessment Questionnaire (PSAQ) was completed at the 3 month follow up (scheduled at the 6 week post op visit). Higher scores reflect a poorer perception of the scar related to the domain being evaluated. The Satisfaction with Symptoms subscale consists of a 5 items with 4-point categorical responses, scoring 1 to 4 points (with 1 point assigned to the most favourable category and 4 assigned to the least favourable). The minimum score of this scale is an 5 and maximum 20.
Time frame: up to 3 month follow up visit (18 weeks post op)
Population: Satisfaction with Appearance at 3 month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Robotic Surgery | Satisfaction With Symptoms Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visit | 5.50 score on a scale | Standard Deviation 1 |
| Open Surgery | Satisfaction With Symptoms Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visit | 7 score on a scale | Standard Deviation 2.74 |
Total Dose of Narcotic Pain Medication In the First 24 Hours Post Op in Morphine Milligram Equivalents (MME)
Pain medication use during hospitalization obtained via retrospective chart review. Morphine milligram equivalents (MME) are values that represent the potency of an opioid dose relative to morphine
Time frame: Surgery to the first 24 hours post op
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Robotic Surgery | Total Dose of Narcotic Pain Medication In the First 24 Hours Post Op in Morphine Milligram Equivalents (MME) | 1.2 MME | Standard Deviation 1.1 |
| Open Surgery | Total Dose of Narcotic Pain Medication In the First 24 Hours Post Op in Morphine Milligram Equivalents (MME) | 0.500 MME | Standard Deviation 0.55 |